Virtus ETF Advisers LLC Kronos Bio, Inc. Transaction History

Virtus ETF Advisers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.12 - $7.52 $36,953 - $89,066	-11,844 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.26 - $14.42 $4,407 - $10,151	-704 Reduced 5.61%	11,844 $86,000
Q4 2021 Feb 14, 2022	BUY	$11.35 - $21.18 $50,189 - $93,657	4,422 Added 54.42%	12,548 $171,000
Q3 2021 Nov 15, 2021	SELL	$18.17 - $24.7 $7,776 - $10,571	-428 Reduced 5.0%	8,126 $170,000
Q2 2021 Aug 10, 2021	BUY	$20.08 - $29.02 $171,764 - $248,237	8,554 New	8,554 $205,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $51.1M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.